Company Description
Hamilton Lane Incorporated is a private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.
The firm manages alternative investment strategies like direct credit, direct, fund of fund, evergreen and real assets.
For primary and secondary fund of fund investments, the firm focuses to invest in private equity, buyout, special situations, credit, growth equity, middle market, mature, turnarounds, mezzanine and venture capital funds.
The firm prefers to invest in disruptive technologies and innovative companies. It prefers to invest in space, engine, alternative energy resources, environmental & facilities services, households durables, leisure products, textiles, manufacturing services, water purification, online training service, healthcare services & technology, energy, industrials, commercial services, internet software & services, consumer discretionary, health care, real estate, information technology, tech-enabled businesses, financials, utilities, and consumer services.
The firm prefers to invest in Africa/Middle East, Asia/Pacific, Europe, Latin America and Caribbean, United States of America, New York, Florida, Arizona, Nevada, New Mexico, Oregon, Washington, California and surrounding states, Australia, Japan, Brazil, United Kingdom, and Canada.
The firm prefers to invest between $0.25 million and $100 million in companies with small- to mid-sized enterprise values.
It prefers to take majority stake. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, Asia Pacific and the Middle East.
| Country | United States |
| Founded | 1991 |
| IPO Date | Mar 1, 2017 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 760 |
| CEO | Erik R. Hirsch |
Contact Details
Address: 110 Washington Street, Suite 1300 Philadelphia, Pennsylvania 19428 United States | |
| Phone | 610 934 2222 |
| Website | hamiltonlane.com |
Stock Details
| Ticker Symbol | HLNE |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001433642 |
| CUSIP Number | 407497106 |
| ISIN Number | US4074971064 |
| Employer ID | 26-2482738 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Dr. Juan M. Delgado-Moreira C.F.A., Ph.D. | Co-Chief Executive Officer and Member of the Board |
| Erik R. Hirsch | Co-Chief Executive Officer and Member of the Board |
| Mario Lucio Giannini J.D. | Executive Co-Chairman |
| Andrea F. Kramer | Chief Operating Officer and Chief Risk Officer |
| Jeffrey B. Armbrister | Chief Financial Officer |
| Drew T. Carl CPA | MD and Chief Accounting Officer |
| Lydia A. Gavalis J.D. | General Counsel |
| Hartley Raymond Rogers | Executive Co-Chairman |
| Thomas J. Kerr | Co-Head of Investments and Co-Head of Secondary Investments |
| Richard Hope | Head of EMEA and Co-Head of Investments |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 24, 2025 | 8-K | Current Report |
| May 30, 2025 | 10-K | Annual Report |
| May 29, 2025 | 8-K | Current Report |
| May 5, 2025 | SCHEDULE 13G/A | Filing |
| Apr 24, 2025 | SCHEDULE 13G/A | Filing |
| Apr 2, 2025 | SCHEDULE 13D/A | Filing |
| Feb 14, 2025 | SCHEDULE 13D/A | Filing |
| Feb 12, 2025 | 8-K | Current Report |
| Feb 11, 2025 | 424B5 | Filing |
| Feb 10, 2025 | 424B5 | Filing |